Personalized cancer vaccine from Moderna, Merck shows promise in first late-stage melanoma trial
The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.
Last updated: 2026-08-21 22:10:54 ET
The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.
FORT Robotics, a safety platform developing a “trust layer” for physical AI, and Newbury Street II Acquisition Corp, a special purpose acquisition...
Enterprise teams running AI agents at scale are finding that a single model handles every task poorly — either the model is too expensive for simple...
Young researchers have long come to the U.S. for academic training, but a combination of Chinese money and U.S. restrictions is shifting the balance.
A predictive maintenance system can flag rising vibration, unusual temperature patterns, or a combination of signals that suggests a component is like...
Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE